// company-profile
Actuate Therapeutics, Inc.
ACTUExchangeNasdaqSectorPharmaceutical PreparationsInc.DEFilings40Insiders37
// api This Actuate Therapeutics, Inc. insider-trading data is served live by the Form4API insider trading API. Get the same data via API.
// activity-summary
No insider transactions in the last 30 days.
// 90-day insight
Over the last 90 days, Actuate Therapeutics, Inc. insiders bought $0 across 10 transactions with no open-market sales.
- Most active insider: Fletcher Aaron G.L. with 1 transaction totaling $0.
Activity skews bullish — buys outpace sales.
Institutional Ownership
Top 13F-HR holders of Actuate Therapeutics, Inc. as of 2026-03-31
Total reported AUM
$37.6M
QoQ change
-51.5%
Reporting period
2026-03-31
#1
BIOS Capital Management, LP
CIK 1813845
$23.5M
8.6M shares
#2
Voss Capital, LP
CIK 1730145
$4.7M
1.7M shares
#3
BIOS Capital Management, LP
CIK 1813845
$4.0M
1.5M shares
Data source: SEC Form 13F-HR filings. Joined with insider activity above — see who's loading up institutionally while insiders are trading. Full 13F-HR API →
Insider Transactions
Sourced from SEC EDGAR Form 4 filings. Updated hourly.
| Date | Insider | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| May 21, 2026 | Fletcher Aaron G.L. | ACTU | Award | 15,000 | $0.00 | $0K |
| May 21, 2026 | Huber Martin H. Jr. | ACTU | Award | 15,000 | $0.00 | $0K |
| May 21, 2026 | RONNEBERG AMY L | ACTU | Award | 15,000 | $0.00 | $0K |
| May 21, 2026 | Sawhney Roger | ACTU | Award | 15,000 | $0.00 | $0K |
| May 21, 2026 | THOMSON TODD S | ACTU | Award | 15,000 | $0.00 | $0K |
45 more transactions hidden
Free account · No credit card required
Building something? Get API access →
Popular companies on Form4API
Browse insider trading activity for other actively-filed companies.